NO893387L - Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering. - Google Patents

Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering.

Info

Publication number
NO893387L
NO893387L NO89893387A NO893387A NO893387L NO 893387 L NO893387 L NO 893387L NO 89893387 A NO89893387 A NO 89893387A NO 893387 A NO893387 A NO 893387A NO 893387 L NO893387 L NO 893387L
Authority
NO
Norway
Prior art keywords
somatotropines
mutagenese
cyste
restrictions
stabilization
Prior art date
Application number
NO89893387A
Other languages
English (en)
Norwegian (no)
Other versions
NO893387D0 (no
Inventor
Susan Mancini Cady
John Steele Logan
Brian Lee Buckwalter
Gerald W Stockton
Deborah Tardy Chaleff
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO893387D0 publication Critical patent/NO893387D0/no
Publication of NO893387L publication Critical patent/NO893387L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO89893387A 1988-08-24 1989-08-23 Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering. NO893387L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23606088A 1988-08-24 1988-08-24
US37269989A 1989-07-03 1989-07-03

Publications (2)

Publication Number Publication Date
NO893387D0 NO893387D0 (no) 1989-08-23
NO893387L true NO893387L (no) 1990-02-26

Family

ID=26929421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893387A NO893387L (no) 1988-08-24 1989-08-23 Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering.

Country Status (18)

Country Link
US (1) US5891840A (el)
EP (1) EP0355460B1 (el)
JP (1) JP2894355B2 (el)
AR (1) AR245138A1 (el)
AT (1) ATE198353T1 (el)
AU (1) AU630105B2 (el)
DE (1) DE68929273T2 (el)
DK (1) DK416589A (el)
ES (1) ES2154627T3 (el)
FI (1) FI104908B (el)
GR (1) GR3035608T3 (el)
HU (1) HU217095B (el)
IE (1) IE892706A1 (el)
IL (1) IL91156A (el)
NO (1) NO893387L (el)
NZ (1) NZ230342A (el)
PT (1) PT91512B (el)
YU (1) YU163289A (el)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2580303B2 (ja) * 1987-02-19 1997-02-12 ジ・アップジョン・カンパニー 異種蛋白をコ−ド付けするcDNA類、発現ベクタ−類および宿主類
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5951972A (en) * 1990-05-04 1999-09-14 American Cyanamid Company Stabilization of somatotropins and other proteins by modification of cysteine residues
ES2113354T3 (es) * 1990-05-04 1998-05-01 American Cyanamid Co Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina.
DK168790D0 (el) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
US6894023B1 (en) 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
NZ240718A (en) * 1990-11-30 1996-10-28 Bio Technology General Corp Somatotropin analogues carrying mutations in the alpha-helix-1 region
US5310882A (en) * 1990-11-30 1994-05-10 American Cyanamid Company Somatotropins with alterations in the α-helix 3 region
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production
FR2671554A1 (fr) * 1991-01-11 1992-07-17 Clonatec Sa Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
AU654563B2 (en) * 1991-07-24 1994-11-10 Imperial Chemical Industries Plc Proteins
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
WO1999003887A1 (en) 1997-07-14 1999-01-28 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
US7270809B2 (en) 1997-07-14 2007-09-18 Bolder Biotechnology, Inc. Cysteine variants of alpha interferon-2
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
JP4873818B2 (ja) 2000-05-16 2012-02-08 ボルダー バイオテクノロジー, インコーポレイテッド 遊離システイン残基を含有するタンパク質をリフォールディングする方法
US6878861B2 (en) 2000-07-21 2005-04-12 Washington State University Research Foundation Acyl coenzyme A thioesterases
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
EP1539960B1 (en) * 2002-09-09 2010-04-28 Hanall Pharmaceutical Co., Ltd. Protease-resistant modified interferon alpha polypeptides
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US8329866B2 (en) 2005-10-03 2012-12-11 Bolder Biotechnology, Inc. Long acting VEGF inhibitors and methods of use
DK1931379T3 (da) 2005-10-07 2013-08-19 Sec Dep For Health Proteiner med forbedret opløselighed samt fremgangsmåder til frembringelse og anvendelse af samme
EP2102355B1 (en) 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
AU2009279090A1 (en) * 2008-08-06 2010-02-11 Novo Nordisk Health Care Ag Conjugated proteins with prolonged in vivo efficacy
JP5816097B2 (ja) * 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
US8841249B2 (en) 2009-08-06 2014-09-23 Novo Nordisk A/S Growth hormones with prolonged in-vivo efficacy
AU2010341516B2 (en) * 2009-12-21 2014-01-16 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
AU2011208625C1 (en) 2010-01-22 2022-08-18 Novo Nordisk Health Care Ag Growth hormones with prolonged in-vivo efficacy
AU2011208620B2 (en) 2010-01-22 2015-04-16 Novo Nordisk Health Care Ag Stable growth hormone compounds
ES2737024T3 (es) * 2012-08-31 2020-01-09 Glaxosmithkline Biologicals Sa Proteínas estabilizadas para inmunización contra Staphylococcus aureus
CN105120887A (zh) 2013-04-05 2015-12-02 诺和诺德保健股份有限公司 生长激素化合物制剂
KR20180003677A (ko) * 2016-06-30 2018-01-10 주식회사 크레아플래닛 인간 성장호르몬 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
JPH04502762A (ja) * 1989-01-19 1992-05-21 ジ・アップジョン・カンパニー ソマトトロピン・アナログ
EP0456642A1 (en) * 1989-01-31 1991-11-21 The Upjohn Company Somatotropin analogs
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
IL91156A (en) 1995-05-26
FI893963A0 (fi) 1989-08-23
YU163289A (en) 1992-05-28
DK416589A (da) 1990-02-25
DE68929273D1 (de) 2001-02-01
AR245138A1 (es) 1993-12-30
JPH034797A (ja) 1991-01-10
AU630105B2 (en) 1992-10-22
PT91512B (pt) 1995-05-31
IL91156A0 (en) 1990-03-19
NO893387D0 (no) 1989-08-23
FI893963A (fi) 1990-02-25
EP0355460B1 (en) 2000-12-27
EP0355460A3 (en) 1991-04-03
FI104908B (fi) 2000-04-28
HU217095B (hu) 1999-11-29
IE892706A1 (en) 1991-01-16
DE68929273T2 (de) 2001-07-05
ATE198353T1 (de) 2001-01-15
GR3035608T3 (en) 2001-06-29
NZ230342A (en) 1992-08-26
AU4020289A (en) 1990-03-15
PT91512A (pt) 1990-03-08
US5891840A (en) 1999-04-06
JP2894355B2 (ja) 1999-05-24
DK416589D0 (da) 1989-08-23
EP0355460A2 (en) 1990-02-28
IE892706L (en) 1990-02-24
ES2154627T3 (es) 2001-04-16
HUT51331A (en) 1990-04-28

Similar Documents

Publication Publication Date Title
NO893387L (no) Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering.
NO895083L (no) Varmestabilisert sukralosepreparat, samt fremgangsmaate for fremstilling av et slikt.
FI891767A0 (fi) Foerfarande foer framstaellning av en ljusvaogledare.
FI912565A0 (fi) Absorptiokappale
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO895067L (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose eller alfa, d-allofuranose.
NO892068D0 (no) Fremgangsmaate ved fremstilling av naftatiozepinoner.
NO894173D0 (no) Fremgangsmaate ved fremstilling av kloridoksid.
FI902100A0 (fi) Foerpackning foer upphettande eller kokande av en matprodukt i en hetluftsugn.
FI896203A (fi) En eller flerskikts inloppslaoda med utvidgad rwglerzon av genomloppsvolym.
FI910340A0 (fi) Anordning foer anvaendning av svetselektroder eller svetstaenger i en motstaendsvetsmaskin.
FI882949A0 (fi) Foerfarande foer xerografisk tryckning av textilmaterial eller dylikt.
NO894762D0 (no) Fremgangsmaate for bygging av hengebro.
FI881649A0 (fi) Anordning foer vaermning av en vattenbaedd.
FI884618A0 (fi) Anordning foer taendning och stabilisering av en svetsbaoge.
NO891898D0 (no) Fremgangsmaate ved fremstilling av naftotiazepinoner.
FI880733A (fi) Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol.
FI902087A0 (fi) Anordning foer styrning av likriktare.
KR890017723U (ko) 금고문의 전자식 괘, 해정장치
FI880029A0 (fi) Anordning foer sammanfogning av byggelement.
FI896348A (fi) Anordning foer bearbetning av stenelement, speciellt hoernstenelement foer en eldstad.
FI913516A (fi) Anordning foer syresaettning av vatten, saerskilt i naturbassaenger, saosom sjoear
FI894354A (fi) Formanordning foer bildande av ett vattenavledningsspaor i asfaltkanten.
NO883849L (no) Anordning ved gassreguleringsanordning eller liknende.
FI883463A (fi) Anordning foer undervattensarbete.